1. Home
  2. APGE vs SID Comparison

APGE vs SID Comparison

Compare APGE & SID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • SID
  • Stock Information
  • Founded
  • APGE 2022
  • SID 1941
  • Country
  • APGE United States
  • SID Brazil
  • Employees
  • APGE N/A
  • SID N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • SID Steel/Iron Ore
  • Sector
  • APGE Health Care
  • SID Industrials
  • Exchange
  • APGE Nasdaq
  • SID Nasdaq
  • Market Cap
  • APGE 2.0B
  • SID 1.9B
  • IPO Year
  • APGE 2023
  • SID 1997
  • Fundamental
  • Price
  • APGE $37.29
  • SID $1.29
  • Analyst Decision
  • APGE Strong Buy
  • SID Strong Sell
  • Analyst Count
  • APGE 4
  • SID 1
  • Target Price
  • APGE $97.50
  • SID $1.30
  • AVG Volume (30 Days)
  • APGE 576.9K
  • SID 3.4M
  • Earning Date
  • APGE 08-11-2025
  • SID 07-31-2025
  • Dividend Yield
  • APGE N/A
  • SID 6.40%
  • EPS Growth
  • APGE N/A
  • SID N/A
  • EPS
  • APGE N/A
  • SID N/A
  • Revenue
  • APGE N/A
  • SID $8,202,474,486.00
  • Revenue This Year
  • APGE N/A
  • SID $5.87
  • Revenue Next Year
  • APGE N/A
  • SID $0.47
  • P/E Ratio
  • APGE N/A
  • SID N/A
  • Revenue Growth
  • APGE N/A
  • SID 2.22
  • 52 Week Low
  • APGE $26.20
  • SID $1.26
  • 52 Week High
  • APGE $63.50
  • SID $2.50
  • Technical
  • Relative Strength Index (RSI)
  • APGE 46.88
  • SID 37.44
  • Support Level
  • APGE $36.74
  • SID $1.31
  • Resistance Level
  • APGE $38.92
  • SID $1.41
  • Average True Range (ATR)
  • APGE 1.78
  • SID 0.05
  • MACD
  • APGE 0.07
  • SID -0.01
  • Stochastic Oscillator
  • APGE 53.44
  • SID 11.90

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About SID Companhia Siderurgica Nacional S.A.

Companhia Siderurgica Nacional is an integrated steel producer. together with its subsidiaries operates in five main business segments: Steel industry: production and marketing of flat and long steels; Mining: extraction, processing and marketing of iron ore, tin, limestone and dolomite; Cement: production and commercialization of bagged and bulk cement, in addition to aggregates, concrete, and other related products; Energy: generation and sale of energy from almost all renewable sources; and Logistics: participations in railways and port terminals. The group generates the majority of its revenue from the Steel industry segment. Geographically, it derives a majority of revenue from Asia.

Share on Social Networks: